4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-018862
Chief Business Officer sold 35,000 shares at an average $19.55 ($684,395)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2022-05-17 | Sale | −28,745 | $19.55 | $561,965 | 42,701 | D |
| Robb Gary Charles Chief Business Officer | 2022-05-18 | Sale | −128 | $19.55 | $2,502 | 42,573 | D |
| Robb Gary Charles Chief Business Officer | 2022-05-19 | Sale | −6,127 | $19.57 | $119,928 | 36,446 | D |
| Open-market sales · 35,000 sh · avg $19.55 · $684,395 | |||||||
Loading xslF345X03/doc4.xml…